{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T21:35:54Z","timestamp":1775165754949,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005946","name":"Hokkaido University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0108657"],"award-info":[{"award-number":["JP23fk0108657"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0108657"],"award-info":[{"award-number":["JP25fk0108657"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fm0208101"],"award-info":[{"award-number":["JP24fm0208101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24jk0210001h0001"],"award-info":[{"award-number":["24jk0210001h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0108657"],"award-info":[{"award-number":["JP24fk0108657"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fm0208101"],"award-info":[{"award-number":["JP25fm0208101"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.virol.2025.110557","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:39:24Z","timestamp":1745980764000},"page":"110557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Exploring suramin's antiviral effects: targeting Lymphocytic Choriomeningitis virus cell entry and replication\/transcription processes"],"prefix":"10.1016","volume":"609","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-2272","authenticated-orcid":false,"given":"Shuzo","family":"Urata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110557_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1999.9723","article-title":"The polysulfonated compound suramin blocks adsorption and lateral diffusion of herpes simplex virus type-1 in vero cells","volume":"258","author":"Aguilar","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110557_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110557_bib3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110557_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/v12030314","article-title":"Suramin inhibits chikungunya virus replication by interacting with virions and blocking the early steps of infection","volume":"12","author":"Albulescu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110557_bib5","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1128\/JVI.01635-12","article-title":"Arenavirus infection induces discrete cytosolic structures for RNA replication","volume":"86","author":"Baird","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2025.110557_bib7","article-title":"Effects of suramin on polycystic kidney disease in a mouse model of polycystin-1 deficiency","volume":"23","author":"Chang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2025.110557_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2018.10.019","article-title":"Zika virus NS2B\/NS3 proteinase: a new target for an old drug - suramin a lead compound for NS2B\/NS3 proteinase inhibition","volume":"160","author":"Coronado","year":"2018","journal-title":"Antivir. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2025.110557_bib9","first-page":"E57","article-title":"Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses","volume":"1171","author":"de la Torre","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.virol.2025.110557_bib10","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/AAC.03595-14","article-title":"Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin","volume":"58","author":"Ellenbecker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110557_bib11","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0900088106","article-title":"Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest","volume":"106","author":"Emonet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2025.110557_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.virol.2011.01.013","article-title":"Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies","volume":"411","author":"Emonet","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110557_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virol.2019.01.019","article-title":"Role of heparan sulfate in the Zika virus entry, replication, and cell death","volume":"529","author":"Gao","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110557_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<238::AID-JMV5>3.0.CO;2-G","article-title":"Suramin blocks hepatitis C binding to human hepatoma cells in vitro","volume":"57","author":"Garson","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib15","series-title":"Structure and Stabilization of the Antigenic Glycoprotein Building Blocks of the New World Mammarenavirus Spike Complex","author":"Guido","year":"2024"},{"key":"10.1016\/j.virol.2025.110557_bib16","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.1128\/JVI.00220-08","article-title":"Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome","volume":"82","author":"Hass","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Henss","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2025.110557_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139001","article-title":"Structural analysis of monomeric RNA-dependent polymerases: evolutionary and therapeutic implications","volume":"10","author":"Jacome","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110557_bib19","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.00672-13","article-title":"Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential","volume":"87","author":"Jiao","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2009.02.042","article-title":"Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction","volume":"387","author":"Kunz","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110557_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","article-title":"Suramin treatment reduces chikungunya pathogenesis in mice","volume":"134","author":"Kuo","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110557_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s42003-023-04789-z","article-title":"Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions","volume":"6","author":"Kwon","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.virol.2025.110557_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF00685609","article-title":"Suramin: an anticancer drug with unique biological effects","volume":"32","author":"Larsen","year":"1993","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.virol.2025.110557_bib24","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.74.8.3470-3477.2000","article-title":"NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs","volume":"74","author":"Lee","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib25","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1073\/pnas.221447598","article-title":"The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1\/S1P","volume":"98","author":"Lenz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2025.110557_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.6091268","article-title":"Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III","volume":"226","author":"Mitsuya","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110557_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005184","article-title":"The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate","volume":"11","author":"Nishimura","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2025.110557_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/v11080745","article-title":"A comprehensive superposition of viral polymerase structures","volume":"11","author":"Peersen","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110557_bib29","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1073\/pnas.2133782100","article-title":"The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies","volume":"100","author":"Perez","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2025.110557_bib30","first-page":"784","article-title":"Arenaviridae: the VIruses and their replication","volume":"1","author":"Radoshitzky","year":"2020","journal-title":"Fields Virolol."},{"key":"10.1016\/j.virol.2025.110557_bib31","article-title":"Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A","volume":"7","author":"Ren","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110557_bib32","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1128\/JVI.02392-07","article-title":"Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib33","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1128\/JVI.77.19.10700-10705.2003","article-title":"Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]","volume":"77","author":"Strecker","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.antiviral.2017.04.017","article-title":"Polysulfonate suramin inhibits Zika virus infection","volume":"143","author":"Tan","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110557_bib35","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.1074\/jbc.RA118.006797","article-title":"The anti-parasitic drug suramin potently inhibits formation of seminal amyloid fibrils and their interaction with HIV-1","volume":"294","author":"Tan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2025.110557_bib36","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1128\/JVI.00512-14","article-title":"Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus","volume":"88","author":"Tani","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.1064265","article-title":"Identification of Surfactin as an anti-Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) multiget compound extracted from the culture broth of marine microbes","volume":"2","author":"Urata","year":"2023","journal-title":"Front Virol."},{"key":"10.1016\/j.virol.2025.110557_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/180326","article-title":"Arenavirus budding","volume":"2011","author":"Urata","year":"2011","journal-title":"Adv Virol"},{"key":"10.1016\/j.virol.2025.110557_bib39","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1099\/vir.0.000105","article-title":"Cis- and cell type-dependent trans-requirements for Lassa virus-like particle production","volume":"96","author":"Urata","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib40","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1128\/JVI.80.8.4191-4195.2006","article-title":"Cellular factors required for Lassa virus budding","volume":"80","author":"Urata","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib41","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1128\/JVI.01012-09","article-title":"The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs","volume":"83","author":"Urata","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/JVI.02019-10","article-title":"Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease","volume":"85","author":"Urata","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib43","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/JVI.06604-11","article-title":"The PI3K\/akt pathway contributes to arenavirus budding","volume":"86","author":"Urata","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib44","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/JVI.03198-15","article-title":"Analysis of assembly and budding of lujo virus","volume":"90","author":"Urata","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110557_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009996","article-title":"Heparan sulfate proteoglycans serve as alternative receptors for low affinity LCMV variants","volume":"17","author":"Volland","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2025.110557_bib46","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01168-19","article-title":"100 Years of suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2025.110557_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","article-title":"Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin","volume":"28","author":"Yin","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2025.110557_bib48","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-022-05271-2","article-title":"Structure of the Ebola virus polymerase complex","volume":"610","author":"Yuan","year":"2022","journal-title":"Nature"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:57:49Z","timestamp":1762221469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225001709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S0042682225001709"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110557","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring suramin's antiviral effects: targeting Lymphocytic Choriomeningitis virus cell entry and replication\/transcription processes","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110557"}}